Silvia Aguado Ibáñez

Mrs. Silvia Aguado Ibáñez

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2020 in Respiratory Research
Verified
Journal Article
Open access
PDF file
JFJavier Flandes
Javier Flandes
LGLuis Fernando Giraldo-Cadavid
Luis Fernando Giraldo-Cadavid
JAJavier Alfayate
Javier Alfayate
IFIker Fernández-Navamuel
Iker Fernández-Navamuel
CACarlos Agusti
Carlos Agusti
JRJose Robles
Jose Robles
Background: The disposable bronchoscope is an excellent alternative to face the problem of SARS-CoV-2 and other cross infections, but the bronchoscopist's perception of its quality has not been evaluated. Methods: To evaluate the quality of the Ambu-aScope4 disposable bronchoscope, we carried out a cross-sectional study in 21 Spanish pulmonology services. We use a standardized questionnaire completed by the bronchoscopists at the end of each bronchoscopy. The variables were described with absolute and relative frequencies, measures of central tendency and dispersion depending on their nature. The existence of learning curves was evaluated by CUSUM analysis. Results: The most frequent indications in 300 included bronchoscopies was bronchial aspiration in 69.3% and the median duration of these was 9.1 min. The route of entry was nasal in 47.2% and oral in 34.1%. The average score for ease of use, image, and aspiration quality was 80/100. All the planned techniques were performed in 94.9% and the bronchoscopist was satisfied in 96.6% of the bronchoscopies. They highlighted the portability and immediacy of the aScope4TM to start the procedure in 99.3%, the possibility of taking and storing images in 99.3%. The CUSUM analysis showed average scores > 70/100 from the first procedure and from the 9th procedure more than 80% of the scores exceeded the 80/100 score. Conclusions: The aScope4™ scored well for ease of use, imaging, and aspiration. We found a learning curve with excellent scores from the 9th procedure. Bronchoscopists highlighted its portability, immediacy of use and the possibility of taking and storing images.

1 March 2019 in Transplantation Proceedings
Verified
Journal Article
Closed access
GAG.P.L. Ambrocio
G.P.L. Ambrocio
SISilvia Aguado Ibáñez
Silvia Aguado Ibáñez
JCJ. Carrillo
J. Carrillo
RLR. Laporta
R. Laporta
MLM. Lazaro-Carrasco
M. Lazaro-Carrasco
MAM. Aguilar
M. Aguilar

1 April 2022 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
SISilvia Aguado Ibáñez
Silvia Aguado Ibáñez
MAMyriam Pérez Aguilar
Myriam Pérez Aguilar
AVAna Royuela Vicente
Ana Royuela Vicente
CGCristina López García-Gallo
Cristina López García-Gallo
GNGema Díaz Nuevo
Gema Díaz Nuevo
MGMaría Piedad Ussetti Gil
María Piedad Ussetti Gil

28 August 2022 in Respirology
Verified
Journal Article
Closed access
VMVictor Manuel Mora-Cuesta
Victor Manuel Mora-Cuesta
DFDavid Iturbe Fernández
David Iturbe Fernández
SISilvia Aguado Ibáñez
Silvia Aguado Ibáñez
GFGabriel Anguera de Francisco
Gabriel Anguera de Francisco
JIJuan Margallo Iribarnegaray
Juan Margallo Iribarnegaray
JCJosé Manuel Cifrián
José Manuel Cifrián

25 September 2018 in Medical Sciences
Verified
Journal Article
Open access
PDF file
RRRosa Malo de Molina Ruiz
Rosa Malo de Molina Ruiz
SISilvia Aguado Ibáñez
Silvia Aguado Ibáñez
CSCarlos Arellano Serrano
Carlos Arellano Serrano
MVManuel Valle
Manuel Valle
MGMARIA PIEDAD USSETTI GIL
MARIA PIEDAD USSETTI GIL
Patients with chronic obstructive pulmonary disease (COPD) have a higher risk of acute cardiovascular events, and around 30% die from cardiovascular diseases. Recent data suggest an increased risk of myocardial infarction in the following days of a severe exacerbation of COPD. Disruption in the balance during the exacerbation with tachycardia, increased inflammation and systemic oxidative stress as well as some other factors may confer an increased risk of subsequent cardiovascular events. A number of investigations may be useful to an early diagnosis, including electrocardiography, imaging techniques and blood test for biomarkers. Some drugs that have changed prognosis in the cardiovascular setting such as cardioselective beta-blockers may be underused in patients with COPD despite its demonstrated benefits. This review focuses on several aspects of exacerbation of COPD and cardiovascular events including epidemiology, possible mechanism, diagnosis and treatment.

25 June 2023 in Transplantology
Verified
Journal Article
Open access
PDF file
SISilvia Aguado Ibáñez
Silvia Aguado Ibáñez
RLRosalía Laporta
Rosalía Laporta
MPMyriam Aguilar Pérez
Myriam Aguilar Pérez
CFChristian García Fadul
Christian García Fadul
CGCristina López García Gallo
Cristina López García Gallo
MGMARIA PIEDAD USSETTI GIL
MARIA PIEDAD USSETTI GIL
The usefulness of bronchoalveolar lavage fluid (BALF) to support the diagnosis of acute cellular (ACR) rejection in lung transplant (LTX) recipients remains controversial. ACR has been associated with blood eosinophil counts (EOS) in other solid organ recipients, but there are few studies in relation to lung transplants. Our aim was to assess the usefulness of the combined analysis of BALF cellularity and EOS for the diagnosis of ACR in lung transplant recipients. This is a retrospective study of findings observed simultaneously in 887 transbronchial biopsies (TBB), BALF, and blood samples obtained from 363 LTx patients transplanted between 2014 and 2020. The variables collected were: demographics, ACR degree, BALF cellularity, and simultaneous blood EOS counts. The lymphocyte count in BALF was significantly higher in patients with ACR than in those without (11.35% vs. 6.11%; p < 0.001). In parallel, EOS counts were also significantly higher in patients with ACR than in the non-ACR group (EOS 213 ± 206/mm3 vs. 83 ± 129/mm3; p < 0.001). Increases in both parameters were associated with an increased risk of ACR (lymphocytes OR 1.100; 95% CI 1.080–1.131; EOS OR 1.460; 95% CI 1.350–1.580). The diagnostic specificity of ACR for a lymphocyte count > 12% was 71.1%, which increased to 95.8% when taking into account a simultaneous blood EOS count > 200/mm3. Simultaneous assessment of BALF lymphocyte counts and blood eosinophil counts may be useful for diagnosing ACR in patients with risk factors for TBB or in the presence of inconclusive histological samples.